John Lunger Insider Trading $ADAP Adaptimmune Therapeutics PLC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Lunger.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Lunger. John Lunger is Chief Patient Supply Officer in Adaptimmune Therapeutics PLC ($ADAP).
John Lunger in Adaptimmune Therapeutics PLC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John Lunger: Chief Patient Supply Officer
Holdings: 7,346 shares
Current Value: $33,277
Latest Transaction: Jan 19 2021
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John Lunger in Adaptimmune Therapeutics PLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 5.67 | 4,358 | 24,708 | 7,346 | 11.7 K to 7.3 K (-37.24 %) |
| Jan 12 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 6.15 | 1,058 | 6,509 | 1,767 | 2.8 K to 1.8 K (-37.45 %) |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Option Exercise | A | 0.00 | 242,712 | 340 | 242,712 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Option Exercise | A | 1.03 | 1,086,816 | 1,119,420 | 1,086,816 | |
| Jan 05 2021 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 5.33 | 1,065 | 5,674 | 1,760 | 2.8 K to 1.8 K (-37.70 %) |
| Aug 04 2020 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 9.25 | 4,823 | 44,613 | 8,066 | 12.9 K to 8.1 K (-37.42 %) |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Option Exercise | A | 0.00 | 280,896 | 365 | 280,896 | |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Option Exercise | A | 0.74 | 1,257,744 | 930,731 | 1,257,744 | |
| Jan 15 2020 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 5.13 | 1,144 | 5,874 | 1,681 | 2.8 K to 1.7 K (-40.50 %) |
| Jan 07 2020 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 1.20 | 1,148 | 1,378 | 1,677 | 2.8 K to 1.7 K (-40.64 %) |
| Aug 05 2019 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Option Exercise | A | 0.00 | 187,500 | 225 | 187,500 | |
| Aug 05 2019 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Option Exercise | A | 0.55 | 839,568 | 461,762 | 839,568 |
Page: 1